Please login to the form below

Not currently logged in

Aurobindo joins Patent Pool

Aurobindo Pharma has become the first generics manufacturer to join the Medicines Patent Pool for the manufacture of HIV/AIDS treatments

Aurobindo Pharma has become the first generics manufacturer to join the Medicines Patent Pool for the manufacture of HIV/AIDS treatments.

The agreement will enable Aurobindo to manufacture products licensed to the Pool by Gilead Sciences in July: emtricitabine, cobicistat, elvitegravir, and the fixed-dose combination of these medicines known as the Quad (a combination of the three drugs and tenofovir).

The Pool said generic manufacturers choosing to develop and manufacture these treatments will help close the gap between the arrival of new medical technology in developed country markets and its often delayed arrival in developing countries.

Aurobindo has chosen not to take a licence on tenofovir, on which there is currently no product patent in India, meaning the company does not have to pay royalties on the product.

The Medicines Patent Pool, founded with the support of UNITAID in 2010, aims to bring down the prices of HIV medicines, and stimulate the development of needed new formulations, through access-oriented voluntary licences.

The Pool's voluntary licences are negotiated to maximise their public health impact.

PV Ramaprasad Reddy, chairman of Aurobindo, said: "We are excited about both the public health and business opportunities provided by the Patent Pool licences. Aurobindo looks forward to increasing its manufacture of HIV-related products, and expanding its work to cover promising new treatments, for the millions of people living with HIV across the globe."

12th October 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked